Pacific Edge’s American dream

Pacific Edge’s American dream
The US Affordable Care Act can be tricky to navigate. (Image: Getty)
Paul McBeth
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection tool. More than 20 years since listing, after it was spun out of University of Otago research, the company has raised $297.23 million selling shares and convertible preference shares and as people exercised options to fund accumulated losses of $216.8m and counting. That’s not going to change any time soon after the company crashed...

More Markets

Property companies help boost NZ sharemarket
Markets Market Close

Property companies help boost NZ sharemarket

Ryman Healthcare, Argosy Property and Goodman all saw share-price rises.

Tom Raynel 05 Jun 2025
Genesis takes another step in increasing NZ's battery capacity
Markets

Genesis takes another step in increasing NZ's battery capacity

Grid-scale batteries add to the mix, but questions remain over economic viability.

Ian Llewellyn 05 Jun 2025
NZ sharemarket rises strongly on power company gains
Markets Market Close

NZ sharemarket rises strongly on power company gains

Positive day for Mercury and Meridian as well as a2 Milk despite gloom on global front. 

Tom Raynel 04 Jun 2025